Cyclacel corrects board appointment error in Securities Purchase Agreement with David Lazar

Bio Green Med Solution, Inc.

Addendum corrects inadvertent error: Mr. Lazar was not appointed as Board member or Chairman, only has right to appoint one director.
David Natan appointed as designee of Lazar and chairman of audit committee.
Amendment restates Section 2.3(a)(v) to reflect correct intent regarding board appointment and resolutions.
All other terms of the Purchase Agreement remain unchanged and in full force and effect.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.